Fiscal Year 2019 National Institutes of Health Funding in Massachusetts as of December 11, 2018. Data Extracted from NIH Reporter.
| 1 | Novel Anti-Cancer Biologics Targeting Wnt Signaling Pathway | 1R21CA235533-01 | Dong, Min | Boston Children’s Hospital | $233,051 |
| 2 | Degrading Therapeutically Important Kinases Using Small Molecules | 1R01CA218278-01A1 | Gray, Nathanael Schiander | Dana-Farber Cancer Institute | $650,235 |
| 3 | Molecular Mechanisms and Therapeutic Targeting of Pi3k-P110beta/PTEN Signaling in Breast Cancer and Cancer Immunity | 1R01CA233810-01 | Roberts, Thomas M | Dana-Farber Cancer Institute | $497522 |
| 4 | Novel Therapeutic Approaches with Cdk4/6 Inhibitors for Melanoma Treatment | 1R01CA236226-01 | Sicinski, Peter | Dana-Farber Cancer Institute | $477643 |
| 5 | RNA-Binding Proteins as Molecular Integrators That Control the Response of HGSOC to Anti-Cancer Therapies | 1R01CA226898-01A1 | Yaffe, Michael B | Massachusetts Institute of Technology | $536497 |
| 6 | Transforming Mechanisms of Merkel Cell Polyoma Virus | 2R01CA173023-06A1 | Decaprio, James A | Dana-Farber Cancer Institute | $419188 |
| 7 | Targeting Alk Through Degradation and Allosteric Inhibitors | 2R01CA136851-10 | Gray, Nathanael Schiander | Dana-Farber Cancer Institute | $373272 |
| 8 | Evaluating Mass Spectrometry for Intraoperative Tissue Characterization In Breast-Conserving Therapy | 5R01CA201469-04 | Agar, Nathalie | Brigham and Women’s Hospital | $393,849 |
| 9 | Personalized Vaccine for Patients with AML | 5R01CA212649-03 | Avigan, David E | Beth Israel Deaconess Medical Center | $699,542 |
| 10 | Usp7 Inhibitors for the Treatment of Multiple Myeloma | 5R01CA211681-03 | Buhrlage, Sara J | Dana-Farber Cancer Institute | $510,712 |
| 11 | Development of Molecular Probes to Investigate and Drug the Oncogenic Wnt/?-Catenin/Bcl9/B9l Transcriptional Complex | 5R21CA221683-02 | Carrasco, Ruben D | Dana-Farber Cancer Institute | $185,134 |
| 12 | Apobec Proteins As Drivers of Chromosomal Translocations In Solid Cancers | 5R01CA222598-02 | Chiarle, Roberto | Boston Children’s Hospital | $392,740 |
| 13 | Elucidating the Regulation and Function of the NF1 Tumor Suppressor | 5R01CA111754-14 | Cichowski, Karen M | Brigham and Women’s Hospital | $307,135 |
| 14 | Molecular Connections Among UV Exposure; Red Hair; Nevi and Melanoma | 5R01CA193913-04 | Cui, Rutao | Boston University Medical Campus | $366,114 |
| 15 | Discovery and Optimization of Novel Mutant-Selective Allosteric Inhibitors of EGFR T790m | 5R01CA201049-04 | Eck, Michael J | Dana-Farber Cancer Institute | $453,318 |
| 16 | Development of Diagnostic and Prognostic Tests for Esophageal Adenocarcinoma | 5R01CA208599-03 | Godfrey, Tony E | BOSTON UNIVERSITY MEDICAL CAMPUS | $428,383 |
| 17 | Regulation of the LIN28/LET-7 Pathway In Cancer | 5R01CA211328-03 | Gregory, Richard I. | BOSTON CHILDREN’S HOSPITAL, | $392,740 |
| 18 | How Does Malignancy Subvert Platelet Megakaryocytic Biology? | 5R01CA200748-03 | Italiano, Joseph E. | Brigham and Women’s Hospital | $534,417 |
| 19 | Inhibiting Extracellular Hsp90 to Reduce Breast Cancer Metastasis | 5R01CA183119-04 | Jay, Daniel G. | TUFTS UNIVERSITY BOSTON | $366,114 |
| 20 | Mir-199~214 Cluster at the Crossroads of Plasticity and Malignancy In Breastcancer | 5R01CA207322-03 | Karnoub, Antoine Elias | Beth Israel Deaconess Medical Center | $383,865 |
| 21 | Interplay of Mammary Luminal Cells and Environmental Factors in Establishing p53-Deficient Premalignant Field | 5R01CA222560-02 | Li, Zhe | Brigham and Women’s Hospital | $363,522 |
| 22 | Polyploidy; Aneuploidy; and Genome Stability | 5R01CA213404-21 | Pellman, David S | Dana-Farber Cancer Institute | $388,303 |
| 23 | Systemic RNA Delivery to Tumors | 5R01CA200900-04 | Shi, Jinjun | Brigham and Women’s Hospital | $526,391 |
| 24 | Lipid-Dendrimer Micellar Nanocarriers for SIRNA/Drug Co-Delivery In MDR Cancer | 5R01CA200844-04 | Torchilin, Vladimir P | Northeastern University | $339,188 |
| 25 | Reprogramming the Tumor Microenvironment via Self-Amplified RNA (Safer) Circuits | 5R01CA206218-04 | Weiss, Ron | Massachusetts Institute of Technology | $533,720 |
| 26 | Dietary Control of Stem Cells in Physiology and Cancer | 5R01CA211184-03 | Yilmaz, Omer | Massachusetts Institute of Technology | $397,201 |
| 27 | Assays to Identify Prostate Cancer Therapeutics Targeting Antizyme Inhibitor | 5R01CA211646-03 | Zetter, Bruce R. | Boston Children’s Hospital | $396,856 |
The Intersection: Discussions in Medicine, Research, and Policy 